Seizure freedom in pediatric juvenile myoclonic epilepsy: The roles of cognition, chronodependency, and EEG: Seizure outcome in pediatric juvenile myoclonic epilepsy
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Predicting seizure freedom in juvenile myoclonic epilepsy (JME) involves a mix of factors. High academic performance and specific seizure types improve outcomes, while chronodependency and EEG findings can indicate challenges.
Area Of Science
- Neurology
- Epileptology
- Chronobiology
Background
- Juvenile Myoclonic Epilepsy (JME) is a common epilepsy syndrome with variable long-term outcomes.
- Predicting seizure freedom is crucial for effective management and patient counseling.
- Existing prognostic markers may not fully capture the complexity of JME.
Purpose Of The Study
- To identify clinical, chronobiological, and electroencephalographic (EEG) predictors of seizure freedom in pediatric JME patients.
- To evaluate the prognostic utility of classic and novel markers in a real-world setting.
Main Methods
- Retrospective cohort study of 71 pediatric JME patients.
- Data collection included demographics, seizure characteristics, academic performance, comorbidities, antiseizure medication use, and detailed EEG findings.
- Multivariate logistic regression and ROC analyses were used to assess predictors.
Main Results
- 63.4% of patients achieved seizure freedom.
- High academic performance and initial myoclonic seizure type were associated with seizure freedom.
- Chronodependency, focal EEG abnormalities, and hyperventilation response were negative prognostic factors.
Conclusions
- Seizure outcome in pediatric JME is influenced by cognitive, chronobiological, and electrographic factors.
- Integrating these factors enhances prognostication and supports personalized management.
- Early identification of at-risk patients can inform tailored interventions.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Focal aware seizures: In these seizures, the person remains conscious...
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...